113 related articles for article (PubMed ID: 16322382)
1. GH responsiveness varies during the menstrual cycle.
Gleeson HK; Shalet SM
Eur J Endocrinol; 2005 Dec; 153(6):775-9. PubMed ID: 16322382
[TBL] [Abstract][Full Text] [Related]
2. Increased pulsatile, but not basal, growth hormone secretion rates and plasma insulin-like growth factor I levels during the periovulatory interval in normal women.
Ovesen P; Vahl N; Fisker S; Veldhuis JD; Christiansen JS; Jørgensen JO
J Clin Endocrinol Metab; 1998 May; 83(5):1662-7. PubMed ID: 9589674
[TBL] [Abstract][Full Text] [Related]
3. Exercise-induced changes in circulating growth factors with cyclic variation in plasma estradiol in women.
Hornum M; Cooper DM; Brasel JA; Bueno A; Sietsema KE
J Appl Physiol (1985); 1997 Jun; 82(6):1946-51. PubMed ID: 9173963
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of insulin-like growth factor I and insulin-like growth factor-binding protein-1 and -3 in women with regular menstrual cycles.
Wang HS; Lee JD; Soong YK
Fertil Steril; 1995 Jun; 63(6):1204-9. PubMed ID: 7538473
[TBL] [Abstract][Full Text] [Related]
5. Pregnancy-induced changes in insulin-like growth factor I (IGF-I), insulin-like growth factor binding protein 3 (IGFBP-3), and acid-labile subunit (ALS) in patients with growth hormone (GH) deficiency and excess.
Wiesli P; Zwimpfer C; Zapf J; Schmid C
Acta Obstet Gynecol Scand; 2006; 85(8):900-5. PubMed ID: 16862465
[TBL] [Abstract][Full Text] [Related]
6. Serum insulin-like growth factor I (IGF-I), IGF-binding protein-1 and -3, and the acid-labile subunit as serum markers of body composition during growth hormone (GH) therapy in adults with GH deficiency.
Thorén M; Hilding A; Baxter RC; Degerblad M; Wivall-Helleryd IL; Hall K
J Clin Endocrinol Metab; 1997 Jan; 82(1):223-8. PubMed ID: 8989263
[TBL] [Abstract][Full Text] [Related]
7. Changes in serum concentrations of growth hormone, insulin, insulin-like growth factor and insulin-like growth factor-binding proteins 1 and 3 and urinary growth hormone excretion during the menstrual cycle.
Juul A; Scheike T; Pedersen AT; Main KM; Andersson AM; Pedersen LM; Skakkebaek NE
Hum Reprod; 1997 Oct; 12(10):2123-8. PubMed ID: 9402266
[TBL] [Abstract][Full Text] [Related]
8. The impact of dose and route of estrogen administration on the somatotropic axis in normal women.
Lissett CA; Shalet SM
J Clin Endocrinol Metab; 2003 Oct; 88(10):4668-72. PubMed ID: 14557438
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor-I response to a single bolus of growth hormone is increased in obesity.
Gleeson HK; Lissett CA; Shalet SM
J Clin Endocrinol Metab; 2005 Feb; 90(2):1061-7. PubMed ID: 15522943
[TBL] [Abstract][Full Text] [Related]
10. Individual igf-I responsiveness to a fixed regimen of low-dose growth hormone replacement is increased with less variability in obese compared to non-obese adults with severe growth hormone deficiency.
Yuen KC; Cook DM; Rumbaugh EE; Cook MB; Dunger DB
Horm Res; 2006; 65(1):6-13. PubMed ID: 16340214
[TBL] [Abstract][Full Text] [Related]
11. Effect of aromatizable and unaromatizable androgen replacement in hypogonadal men on GH responsiveness.
Gleeson HK; Shalet SM
Clin Endocrinol (Oxf); 2009 Jan; 70(1):109-15. PubMed ID: 18549466
[TBL] [Abstract][Full Text] [Related]
12. The effect of four weeks of supraphysiological growth hormone administration on the insulin-like growth factor axis in women and men. GH-2000 Study Group.
Dall R; Longobardi S; Ehrnborg C; Keay N; Rosén T; Jørgensen JO; Cuneo RC; Boroujerdi MA; Cittadini A; Napoli R; Christiansen JS; Bengtsson BA; Sacca L; Baxter RC; Basset EE; Sönksen PH
J Clin Endocrinol Metab; 2000 Nov; 85(11):4193-200. PubMed ID: 11095453
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of different biochemical markers of the insulin-like growth factor (IGF) family in diagnosing growth hormone excess and deficiency in adults.
Marzullo P; Di Somma C; Pratt KL; Khosravi J; Diamandis A; Lombardi G; Colao A; Rosenfeld RG
J Clin Endocrinol Metab; 2001 Jul; 86(7):3001-8. PubMed ID: 11443159
[TBL] [Abstract][Full Text] [Related]
14. The growth hormone (GH)-insulin-like growth factor axis during testosterone replacement therapy in GH-treated hypopituitary males.
Fisker S; Nørrelund H; Juul A; Skakkebaek NE; Christiansen JS; Jørgensen JO
Growth Horm IGF Res; 2001 Apr; 11(2):104-9. PubMed ID: 11472076
[TBL] [Abstract][Full Text] [Related]
15. Effects of estradiol and exogenous insulin-like growth factor I (IGF-I) on the IGF-I axis during growth hormone inhibition and antagonism.
Wilson ME
J Clin Endocrinol Metab; 1998 Nov; 83(11):4013-21. PubMed ID: 9814485
[TBL] [Abstract][Full Text] [Related]
16. IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age.
Ranke MB; Traunecker R; Martin DD; Schweizer R; Schwarze CP; Wollmann HA; Binder G
Horm Res; 2005; 64(2):68-76. PubMed ID: 16113581
[TBL] [Abstract][Full Text] [Related]
17. Polysomnographic sleep, growth hormone insulin-like growth factor-I axis, leptin, and weight loss.
Rasmussen MH; Wildschiødtz G; Juul A; Hilsted J
Obesity (Silver Spring); 2008 Jul; 16(7):1516-21. PubMed ID: 18464752
[TBL] [Abstract][Full Text] [Related]
18. Growth hormone secretion after baclofen administration in different phases of the menstrual cycle in healthy women.
Orio F; Palomba S; Colao A; Tenuta M; Dentico C; Petretta M; Lombardi G; Nappi C; Orio F
Horm Res; 2001; 55(3):131-6. PubMed ID: 11549874
[TBL] [Abstract][Full Text] [Related]
19. Five-day pulsatile gonadotropin-releasing hormone administration unveils combined hypothalamic-pituitary-gonadal defects underlying profound hypoandrogenism in men with prolonged critical illness.
van den Berghe G; Weekers F; Baxter RC; Wouters P; Iranmanesh A; Bouillon R; Veldhuis JD
J Clin Endocrinol Metab; 2001 Jul; 86(7):3217-26. PubMed ID: 11443192
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of the acid-labile subunit in acromegaly: evaluation in comparison with insulin-like growth factor (IGF) I, and IGF-binding protein-1, -2, and -3.
Arosio M; Garrone S; Bruzzi P; Faglia G; Minuto F; Barreca A
J Clin Endocrinol Metab; 2001 Mar; 86(3):1091-8. PubMed ID: 11238491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
